|Bid||261.00 x 800|
|Ask||265.84 x 800|
|Day's Range||260.42 - 266.26|
|52 Week Range||208.48 - 287.94|
|Beta (3Y Monthly)||1.06|
|PE Ratio (TTM)||20.83|
|Earnings Date||Apr 15, 2019 - Apr 22, 2019|
|Forward Dividend & Yield||3.60 (1.47%)|
|1y Target Est||305.61|
# UnitedHealth Group Inc ### NYSE:UNH View full report here! ## Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is extremely low for UNH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting UNH. ## Money flow ETF/Index ownership | Negative ETF activity is negative and may be weakening. The net inflows of $610 million over the last one-month into ETFs that hold UNH are among the lowest of the last year and appear to be slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap | Negative The current level displays a negative indicator. UNH credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness. Please send all inquiries related to the report to email@example.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
UnitedHealthcare, in partnership with Techstars, is forming a health care startup accelerator that will select 10 startups to participate in a three-month program later this year.
UnitedHealth Group (NYSE:UNH) erased around half of its losses from the December 2018-January 2019 period. Just as markets often get it wrong, it did so again with UNH stock when the company reported strong quarterly reports. With a proven management team, the company has a multiyear growth plan that embraces digitalization. So as UnitedHealth continues to cut costs, operate more effectively and increase revenue, investors will get rewarded. ### UnitedHealth's Fourth-Quarter Results UnitedHealth reported GAAP EPS of $3.10 as revenue grew 12.2% to $58.42 billion. Both figures easily beat the street estimates. Its quarterly results surpassed its own previous forecast, communicated at its Investor Conference outlook meeting. Optum's earnings pulled out ahead because of overall medical cost controls. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Management successfully tackled expenses by executing on both structural costs and rate recovery. This sets up for an even better 2019 performance. * 7 Stocks to Buy as the Dollar Weakens UNH stock is still around 10% below its 52-week high. And at a valuation of 15.6 times forward earnings, the stock may have more upside potential due to the outsized growth. Digitalization, or linking physical interactions to digital channels supported by proprietary data analytics, is already improving performance. The platform already has 22 million registered users that the company may engage with to deliver better service on health promotion and its related finances. The improved interactions between patients and the company will continue to drive profit growth higher. For example, pharmacy care services reported a 98% retention rate. It won new business awards from health plans and employer plans, which already sets the company up for 2020 revenue growth. It is looking more likely that the 15.6 times forward P/E is too low and does not reflect the company's upside over the next few years. ### Growth Drivers for UNH Stock UnitedHealth's two drivers for justifying a higher share price is simple. Lower total medical costs will continue and revenue will go up. Both are connected: by keeping people healthier and avoiding unnecessary hospital visits, costs go down. Commercial customers like this pattern and also join UNH. Looking beyond into 2030, when 80 million people in the U.S. will have three or more chronic conditions, up from 30 million in 2015, it is imperative that UnitedHealth builds its comprehensive portfolio of care delivery services. On the back end, data analytics across all of Optum will help UNH reduce costs while delivering better care to its customers. ### Risks for UnitedHealthcare Ignoring the potential and actual risks in investing in UNH stock would give an incomplete picture to readers. Management expects a health insurance tax will come back in 2020. This will also increase healthcare costs by $20 billion for the 142 million Americans. At $500 in extra costs per family with small business coverage, the customer acquisition rate UNH enjoys today may slow because of this. Despite the headwinds coming up, UnitedHealth will soon realize the benefits of winning a few large corporate deals. In 2020, it will focus more on health plans and then the large employer group. ### Valuation 13 analysts on Wall Street cover UnitedHealth stock and on average, have a $308.90 price target. Every single analyst report in the last month is a "buy" call: Analyst Firm Position Price Target Action Date John Ransom Raymond James Buy $310.00 Reiterated 1 day ago Kevin Fischbeck Merrill Lynch Buy $320.00 Reiterated 1 day ago Michael Wiederhorn Oppenheimer Buy $305.00 Reiterated 2 days ago Sarah James Piper Jaffray Buy -- Reiterated 2 days ago Steven Halper Cantor Fitzgerald Buy $310.00 Reiterated 2 days ago Ana Gupte Leerink Partners Buy $335.00 Reiterated 2 days ago A.J. Rice Credit Suisse Buy $310.00 Reiterated 3 days ago Steve Willoughby Cleveland Research Buy -- Reiterated 6 days ago Steven Valiquette Barclays Buy $279.00 Reiterated 13 days ago Zachary Sopcak Morgan Stanley Buy $315.00 Reiterated Last month David Toung Argus Research Buy $295.00 Reiterated Last m Source: tipranks Investors may have a contrarian viewpoint against Wall Street reports but it is hard to get negative on UNH stock after its Q4 results. Overall, UnitedHealth looks like a slow and steady climber whose stock will reward patient investors. ### Related Investment CVS Health Corporation (NYSE: CVS) is embracing the PBM model through its Express Scripts acquisition. The stock trades at 8.4 times forward P/E and is barely above 52-week lows. Investors are punishing the stock and pricing in the integration risks related to the acquisition. As of this writing, Chris Lau did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Growth Stocks With the Future Written All Over Them * 7 Reasons Why Buffett's Bet on Apple Stock Is a Good One * 10 Companies That Could Post Decelerating Profits Compare Brokers The post UnitedHealth Is a Steady Investment for the Patient Investor appeared first on InvestorPlace.
NEW YORK, Jan. 17, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Bank of America Merrill Lynch analyst Kevin Fischbeck reiterated a Buy rating on UnitedHealth with a $320 price target. UnitedHealth reported balanced earnings upside across UnitedHealthcare and Optum, BofA's Fischbeck said in a Wednesday note.
posted stronger-than-expected fourth quarter earnings Tuesday, and held its 2019 outlook in place, as Optum revenues topped $100 billion for the first time on record last year. UnitedHealth said adjusted earnings for the three months ending in December came in at $3.28 per share, up 26.6% from the same period last year and well ahead of the Street consensus of $3.21. "The 300,000 dedicated women and men of UnitedHealth Group are positively impacting society by restlessly pursuing a mission to help people live healthier lives and to improve health system performance," said CEO David Wichmann.
UnitedHealth Group Inc. said its sales rose in the fourth quarter as the company continued to post diversified growth from health-care-plan membership, premiums and a network of health services. Revenue at the UnitedHealthcare segment rose 11% to $46.2 billion, while sales at the Optum segment increased 13% to 27.6 billion. On an adjusted basis, UnitedHealth reported profit of $3.28 a share, compared with analysts’ estimates of $3.21 a share.
Stocks that moved substantially or traded heavily Tuesday: Netflix Inc., up $21.70 to $354.64 The video streaming company said it will raise prices for its U.S. subscribers. Microsoft Corp., up $2.96 to ...
U.S. stocks rose on Tuesday as technology and internet stocks gained on Netflix Inc's plans to raise fees for U.S. subscribers and hopes of more stimulus for China's slowing economy fostered a risk-on mood among investors. Netflix shares jumped 6.5 percent after the video streaming company said it was raising prices for its U.S. subscribers.
UnitedHealth Group, the nation's largest insurer, reported earnings before the open on Tuesday that exceeded Wall Street expectations. UnitedHealth stock rose in early trade, giving a lift to Dow Jones futures.
The Dow Jones Industrial Average rose Tuesday despite an earnings miss from JPMorgan Chase & Co. JPMorgan Chase earned $1.98 a share in the fourth quarter, missing analysts' estimates of $2.20 by a wide margin. Delta was up slightly.
U.S. stocks rose on Tuesday as technology and internet stocks gained on Netflix Inc's plans to raise fees for U.S. subscribers and hopes of more stimulus for China's slowing economy fostered a risk-on mood among investors. Netflix shares jumped 6.3 percent after the video streaming company said it was raising prices for its U.S. subscribers. Other internet stocks, including shares of Alphabet Inc , Amazon.com Inc and Apple Inc, also rose following the announcement.
Leerink’s Ana Gupte reiterated an Outperform rating on the stock and a $335 price target following the report. She writes that UnitedHealth turned in a “solid top- and bottom-line beat.”
U.S. stocks rose on Tuesday as Netflix spurred a rally in technology and internet stocks and UnitedHealth posted strong results, while hopes of more stimulus for China's slowing economy encouraged buying in risky assets. Netflix Inc shares jumped 7 percent after the video streaming pioneer said it was raising prices for its U.S. subscribers. The communication services sector, which includes Netflix and Facebook, rose 1.64 percent, while technology stocks jumped 1.53 percent.
Ryan McQueeney recaps Netflix's subscription price hike and earnings results from Delta, UnitedHealth, Wells Fargo, and JPMorgan. Later, he chats with Dave Bartosiak about bank earnings and how investors can profit throughout the Q4 report season.
UnitedHealth maintained its previous profit forecast for 2019 adjusted earnings of $14.40 to $14.70 per share, and said higher than expected medical costs in the fourth quarter were limited to states for which it manages their Medicaid benefits, the government program for low income Americans. The company is the first to report earnings for the sector. UnitedHealth shares rose 2.8 percent, or $6.91, to $254.97.